Tietze, Annette (Qiagen 200806 Global Product Manager) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
Germany |
Tigges, Marcel (BioVersys 2008– CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
BioVersys AG |
Switzerland |
Tilgner, Marco (Analytik Jena 201401– Managing Director of AJ Japan) |
Managing Director |
Endress+Hauser (Group) |
Japan |
Tille, Sebastian (Danaher 201108 Leica Microsystems Life Science Division) |
n. a. |
Danaher (Group) |
Germany |
Tillich, Dirk (Hamilton Bonaduz 200707 Head Marketing + Sales, Business Unit Analytics) |
Sales Manager / Marketing Manager |
Hamilton (Group) |
Switzerland |
Tillmann, Michael (Vela 201206 CEO of Vela Diagnostics) |
Chief Executive Officer (CEO) |
Vela (Group) |
Singapore |
Timmers, Jan (Tecan 2006– Senior VP Sales Value Added Reseller Business joined Tecan US 1992) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
Timmler, Burkhard (AiCuris 201301 Medical Director) |
Chief Medical Officer (CMO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Tinazli, Ali (Sony 201112 Director Business Development + Sales North America at Sony DADC) |
Business Development Manager / Strategy Manager |
Stratec (Group) |
United States (USA) |
Tintrup, Hartmut (Cevec 201511– VP Business Developm Gene Therapy/Viruses before CBO joined 2010 before amaxa US) |
Chief Business Officer (CBO) |
Cevec (Group) |
Germany |
Tiringer, Christian (ARAX Capital Partners 201111 Managing Director + Partner) |
Managing Director |
ARAX Capital Partners GmbH |
Austria |
Tisi, Laurence (Lumora 200301 CEO + founder) |
Chief Executive Officer (CEO) |
Erba Diagnostics Mannheim (Group) |
United Kingdom (GB) |
Tjeenk Willink, Engelbert (Boehringer 2009–201212 Managing Director LEFT 12/12) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
Toder, Roland |
n. a. |
Eurofins (Group) |
Germany |
Todt, Horst (Bruker 201309 Product Manager for minispec at Bruker BioSpin) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
Toepfer, Dirk (Merck (DE) 201803– Chief Information Officer before Metro Group + Bertelsmann) |
Chief Information Officer (CIO) / Chief Digital Officer |
Merck (DE) (Group) |
Germany |
Tolcher, Anthony (NEXT-Oncology 201811 CEO + Founder before START (South Texas Accelerated Research Therapeutics)) |
Advisory Board member |
NBE Therapeutics AG |
Switzerland |
Tolnay, Markus (Univ Basel 201704 Manager of Institute of Medical Genetics and Pathology at Univ Hospital Basel) |
President/Director/Head of Research Organisation/Unit |
University of Basel |
Switzerland |
Tombler, Thomas (NanoPin Technologies 202002 CEO) |
Chief Executive Officer (CEO) |
NanoPin Technologies Inc. |
United States (USA) |
Tomsicek, Michael (CRISPR Therapeutics 201711– CFO before Abiomed + Cubist + GE Healthcare) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
Tonkinson, John L. (Epitome Biosystems –200510– Director BusDev before Schleicher & Schuell BioScience) |
Business Development Manager / Strategy Manager |
Epitome Biosystems Inc. |
United States (USA) |
Tooman, Craig A. (Aratana Therapeutics 201901– CEO before CFO since 2013 before Avanzar Medical + Enzon Pharma + Ikaria) |
Chief Executive Officer (CEO) |
Aratana (Group) |
United States (USA) |
Topalidis, Theodoros (CTC North 201304– Managing Director) |
Managing Director |
CTC North (Group) |
Germany |
Topalidis, Wladimiros (CTC North 201304– Managing Director) |
Managing Director |
CTC North (Group) |
Germany |
Topen, Andrew (EuropaBio 202009– Chairman main org Novartis before Pfizer + GSK) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
Topp, Thomas (Cochlear 201009 Cochlear Deutschland GmbH & Co KG) |
n. a. |
|
|
Tormo, Jordi (BASF 201512 VP Global Research Herbicides + Services) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
Torrance, Chris (PhoreMost 201504– CEO + Co-founder before Horizon Discovery Co-founder + Vernalis) |
Chief Executive Officer (CEO) |
PhoreMost Ltd. |
United Kingdom (GB) |
Torti, Frank (Roivant 201808 Vant Investment Chair before New Enterprise Associate 2007–2018) |
Investment Manager |
Roivant (Group) |
Switzerland |
Tostmann, Holger (Trophic Communications GmbH 201710– Managing Director) |
Managing Director |
Trophic Communications GmbH |
Germany |
Tourniaire, Guilhem (Scienion 201610 Managing + Scientific Director of Cellenion SASU) |
Managing Director |
Cellink (Group) |
France |
Traeger, Stefan (Tecan 201307–201706 Head of Life Sciences before Leica Microsystems + Zeiss LEAVES 2017) |
Board member, executive |
Tecan (Group) |
Switzerland |
Tramnitz, Birgit (Medicyte GmbH 201303 Business Development Manager) |
Business Development Manager / Strategy Manager |
Medicyte GmbH |
Germany |
Tramoy, Philippe (Seventure Partners 201504 Investment Director at Quadrivium 1 seed fund) |
Chief Executive Officer (CEO) |
BPCE (Group) |
France |
Trau, Dieter (Ayoxxa 201209 CSO of Ayoxxa Bisoystems GmbH) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ayoxxa (Group) |
Germany |
Traulsen, Fridtjof (Boehringer Ingelheim 201806 Corporate SVP Development) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Trautner, Else Beth (Euro Diagnostica 201101– CEO before CCO before AdvanDx + Dako + Life Technologies) |
Chief Executive Officer (CEO) |
Euro Diagnostica (Group) |
Sweden |
Trautwein, Axel (Bayer 201404 Head of Chemical Crop Protection Research at Bayer CropScience) |
n. a. |
Bayer (Group) |
Germany |
Travers, Stuart (Sentinel Oncology 201605 COO) |
Chief Operating Officer (COO) |
Sentinel Oncology Ltd. |
United Kingdom (GB) |
Traynor, Pete (Thermo Fisher 201403 Process Mass Spectrometry Market Leader) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
Treco, Doug (Ra Pharmaceuticals 20008– CEO + Co-Founder before Transkaryotic Therapies) |
Chief Executive Officer (CEO) |
UCB (Group) |
United States (USA) |
Trede, Dennis (SCiLS GmbH 201212– Managing Director + Steinbeis 201201 Deputy Managing Director SCiLS Bremen) |
Managing Director |
Bruker (Group) |
Germany |
Treder, Martin (Affimed 201701 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Affimed (Group) |
Germany |
Treffer, Udo (MultiSynTech 200902 CEO) |
Chief Executive Officer (CEO) |
MultiSynTech GmbH |
Germany |
Tregay, Steven (Forma Therapeutics 200810–201903 CEO + founder before Novartis Venture Funds Managing Director) |
Chief Executive Officer (CEO) |
Forma Therapeutics (Group) |
United States (USA) |
Tremblay, Marc (Thermo Fisher 201211 President Clinical Diagnostics business) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
Tremmel, Robin (Heidelberg Delivery Technologies 201707– Managing Director) |
Managing Director |
Heidelberg Delivery Technologies GmbH |
Germany |
Trendelenburg, Chr. |
n. a. |
Städtische Kliniken Frankfurt a. M. |
Germany |
Trengove, Robert (Murdoch Univ 201207 Prof + Director Separation Science + Metabolomics Lab) |
Professor |
Murdoch University |
Australia |
Trepte, Claudia (Measurement Valley 201104 Managing Director) |
Managing Director |
Measurement Valley e. V. |
Germany |
Treptow, Rainer (Eppendorf Instrumente 200609 CEO) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
Tressel, Jürgen (Bruker 201710 Head of Tissue Pathology Business Unit at Bruker Daltonics) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Trexler, David R. (MorphoSys 201902– President of MorphoSys US Inc before EMD Serono + Eisai Inc + Mylan Bertek) |
President/Director/Head Business Group/Unit/Division |
MorphoSys (Group) |
United States (USA) |
Triebsch, Carola (Deutsche Messe 2013) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
Trinh, An (Sigma-Aldrich 200904 Product Sample Prep at Supelco) |
Product Manager (personnel) |
Merck (DE) (Group) |
|
Tripatzis, Ioannis |
n. a. |
Medical Park Hannover GmbH |
Germany |
Tripet, Jean-Philippe (Aravis 200205 Managing Director + Board of Directors ESBATech) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
Tripp, Thorsten H. (Brand 200705 Sales Representative Asia/Pacific) |
Sales Manager / Marketing Manager |
Brand (Group) |
Germany |
Tristram, Leo W. (RiNA GmbH 199912–201004– Managing Director+ PLS-Design GmbH 201201 Managing Director) |
Managing Director |
Biotechrabbit (Group) |
Germany |
Trockle, Jochen (Trockle Unternehmensberatung 201207 Managing Director + Founder) |
Managing Director |
Trockle Unternehmensberatung GmbH & Co. KG |
Germany |
Troia, Ken (Biotest 200908 Director Marketing Global Business Unit Microbiology) |
Sales Manager / Marketing Manager |
Creat (Group) |
Germany |
Trombe, Emmanuelle (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
France |
Trost, Matthias (Univ Newcastle 201702 Professor at ICaMB) |
Professor |
University of Newcastle (Newcastle University) |
|
Truehart, Tricia (Trout Group 201712) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
Truex, Samantha (Quench Bio 201810 CEO before Synlogic + Padlock Therapeutics) |
Chief Executive Officer (CEO) |
Quench Bio (US) |
United States (USA) |
Truitt, Ed (Lubris 201206 CEO) |
Chief Executive Officer (CEO) |
Lubris LLC |
United States (USA) |
Trutnau, Hans-H. (Kinomics 200507) |
n. a. |
Kinomics GmbH |
Germany |
Trüeb, Hans Rudolf (Walder Wyss 202009 Senior Partner + Dinaqor 202009– General Counsel + Corporate Secretary) |
Attorney / Lawyer |
Walder Wyss |
|
Tryggvason, Kristian (BioLamina 201303 CEO) |
Chief Executive Officer (CEO) |
BioLamina (Group) |
Sweden |
Tröndle, Norbert (Genaxxon BioScience 200512) |
n. a. |
Genaxxon BioScience GmbH |
Germany |
Trösken, Volker (Amedo 201003 Managing Director) |
Managing Director |
Amedo Smart Tracking Solutions GmbH |
Germany |
Tsai, Charles (Cytena 201907 CEO of Cytena Bioprocess Solutions Co Ltd) |
Chief Executive Officer (CEO) |
Cellink (Group) |
Taiwan |
Tsai, John (Novartis 201908 Head Global Drug Development + CMO) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
Tsao, Doris (Univ of Bremen 200610) |
n. a. |
University of Bremen |
Germany |
Tscheppe, Michael (Nuvonis 201802 Managing Director + Co-Founder) |
Managing Director |
Nuvonis Technologies GmbH |
Austria |
Tschudin, Marie-France (Novartis 201906– President Novartis Pharmaceuticals joined 2017 before 10y at Celgene) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
Tsunaba, Kazunari (Novartis 202003 President + Representative Director Novartis Pharma) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Japan |
Tsybin, Yuri (EPFL 201005 Professor) |
Professor |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
Tuason, Nico (Fluidigm 201502 Senior Product Manager) |
Product Manager (personnel) |
Fluidigm (Group) |
United States (USA) |
Tudorica, Joanne (Trophic Communications 201801 before MacDougall Biomedical Communications) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
Tuffs, Annette (Helmholtz 201710 Head of Communications Dept at MDC) |
Public Relations Manager / Investor Relations Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Tullman, Stephen (Ceptaris Therapeutics 201308 CEO) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
Tulstrup, Søren (Galenica 201408 CEO of Vifor Pharma before Shire + Santaris Pharma 2008–2012 CEO) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
Tur, Christelle (Debiopharm 201504 Communications Coordinator) |
Public Relations Manager / Investor Relations Manager |
Debiopharm (Group) |
Switzerland |
Turgut, Kaya (Turgut Ilaç 201511 Board Chairman + Founder) |
Board member |
Turgut Ilaçlari A.S. |
Turkey |
Turner, Jonathan David (XL Technology Group 2005– SVP BusDev before Boehringer Head Corp BusDev before AstraZeneca) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
Turner, Nat (Flatiron Health 201802 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Turner, Rodney (Ayoxxa 201612– CEO before interim CEO + Supervisory Board Member before Life Technologies + Evotec) |
Chief Executive Officer (CEO) |
Ayoxxa (Group) |
Germany |
Turner, Simon (Alacrita 201706) |
Consultant (economic/technology) |
Alacrita (Group) |
United Kingdom (GB) |
Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) |
Chief Executive Officer (CEO) |
Protea Biosciences (Group) |
United States (USA) |
Tuschl, Thomas (Rockefeller Univ 200601) |
n. a. |
LGC (Group) |
Germany |
Tynes, Thomas E. (MeVis 200709–201204 Exec Board Director Marketing + Sales before Invivo Corp RESIGNED 4/12) |
Chief Commercial Officer (CCO) |
Varian Medical Systems (Group) |
Germany |
Türeci, Özlem (Ganymed 200811 CEO + CSO) |
Chief Executive Officer (CEO) |
Astellas (Group) |
Germany |
Tyrekidis, Joanna (Noshaq 201906 Investment Manager) |
Investment Manager |
Noshaq S.A. |
Belgium |
Tysiak, Michael (Cytolon 201504– CEO before Biobase 200110– joined as CFO became Managing Director) |
Managing Director |
Cytolon AG |
Germany |
Tzalis, Dimitrios (Talos Chemicals 201309 CEO + Founder) |
Chief Executive Officer (CEO) |
Taros Chemicals GmbH & Co. KG |
Germany |
Tzannis, Stelios T. (Aeovian Pharmaceuticals 201910 CEO) |
Chief Executive Officer (CEO) |
|
|
Tzouvalis, Plato (Acrongenomics 200704 President) |
n. a. |
Acrongenomics Inc. |
United Kingdom (GB) |
Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) |
Chief Operating Officer (COO) |
Cevec (Group) |
Germany |
Udier-Blagovic, Marina (Nouscom 202002– CEO joined 201609 as COO before Versant Ventures + Novartis + McKinsey) |
Chief Operating Officer (COO) |
Nouscom (Group) |
Switzerland |